Hypothesis

3 Matching Annotations

Last 7 days
www.sciencedirect.com www.sciencedirect.com

CD4 T cells convert transient responses to KRAS inhibition to durable remissions in pancreatic cancer

1
1. scibot 27 Sep 2026
  
  in Public
  
  RRID:CVCL_YM31
  
  DOI: 10.1016/j.cell.2026.08.045
  
  Resource: (Kerafast Cat# EUP006-FP, RRID:CVCL_YM31)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_YM31
  
  What is this?
  
  RRID:CVCL_YM31
Visit annotations in context

Tags

RRID:CVCL_YM31

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S0092867426010184
May 2026
www.sciencedirect.com www.sciencedirect.com

Dendritic cell redundancy enables priming of anti-tumor CD4+ T cells in pancreatic cancer

1
1. scibot 08 May 2026
  
  in Public
  
  RRID:CVCL_YM31
  
  DOI: 10.1016/j.ccell.2026.04.005
  
  Resource: (Kerafast Cat# EUP006-FP, RRID:CVCL_YM31)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_YM31
  
  What is this?
  
  RRID:CVCL_YM31
Visit annotations in context

Tags

RRID:CVCL_YM31

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S1535610826002163
Apr 2025
pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov

Combination of Bremachlorin PDT and Immune Checkpoint Inhibitor Anti–PD-1 Shows Response in Murine Immunological T-cell–High and T-cell–Low PDAC Models

1
1. scibot 04 Apr 2025
  
  in Public
  
  RRID:CVCL_YM31
  
  DOI: 10.1158/1535-7163.MCT-23-0733
  
  Resource: None
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_YM31
  
  What is this?
  
  RRID:CVCL_YM31
Visit annotations in context

Tags

RRID:CVCL_YM31

Annotators

scibot

URL

pmc.ncbi.nlm.nih.gov/articles/PMC11962392/